Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Sherwin

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancerA A Jakubowski, E S Casper, J L Gabrilove, et al.
Cancer Research|June 1, 1985
Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patientsR Kurzrock, M G Rosenblum, S A Sherwin, et al.
Annals of Internal Medicine|March 1, 1987
NIH conference. Immunomodulators in clinical medicineA S Fauci, S A Rosenberg, S A Sherwin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Phase I study of multiple dose intramuscularly administered recombinant gamma interferonR Kurzrock, J R Quesada, M Talpaz, et al.
The Journal of Experimental Medicine|October 1, 1986
Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patientsR Kurzrock, M F Rohde, J R Quesada, et al.
The American Journal of Medicine|November 1, 1984
Atypical tumor lysis syndrome in a patient with T cell lymphoma treated with recombinant leukocyte interferonM F Fer, G C Bottino, S A Sherwin, et al.
Cellular Immunology|October 15, 1989
Gamma-interferon-induced monocyte major histocompatibility complex class II antigen expression individuals with acquired immune deficiency syndromeO Martínez-Maza, R T Mitsuyasu, S A Miles, et al.
Archives of Dermatology|December 1, 1987
Use of recombinant interferon gamma administered intramuscularly for the treatment of psoriasisV B Morhenn, K Pregerson-Rodan, R H Mullen, et al.
Journal of Biological Response Modifiers|December 1, 1984
A preliminary Phase I trial of partially purified interferon-gamma in patients with cancerS A Sherwin, K A Foon, P G Abrams, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administrationJ A Knost, S A Sherwin, P G Abrams, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancerA A Jakubowski, E S Casper, J L Gabrilove, et al.
Cancer Research|June 1, 1985
Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patientsR Kurzrock, M G Rosenblum, S A Sherwin, et al.
Annals of Internal Medicine|March 1, 1987
NIH conference. Immunomodulators in clinical medicineA S Fauci, S A Rosenberg, S A Sherwin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Phase I study of multiple dose intramuscularly administered recombinant gamma interferonR Kurzrock, J R Quesada, M Talpaz, et al.
The Journal of Experimental Medicine|October 1, 1986
Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patientsR Kurzrock, M F Rohde, J R Quesada, et al.
The American Journal of Medicine|November 1, 1984
Atypical tumor lysis syndrome in a patient with T cell lymphoma treated with recombinant leukocyte interferonM F Fer, G C Bottino, S A Sherwin, et al.
Cellular Immunology|October 15, 1989
Gamma-interferon-induced monocyte major histocompatibility complex class II antigen expression individuals with acquired immune deficiency syndromeO Martínez-Maza, R T Mitsuyasu, S A Miles, et al.
Archives of Dermatology|December 1, 1987
Use of recombinant interferon gamma administered intramuscularly for the treatment of psoriasisV B Morhenn, K Pregerson-Rodan, R H Mullen, et al.
Journal of Biological Response Modifiers|December 1, 1984
A preliminary Phase I trial of partially purified interferon-gamma in patients with cancerS A Sherwin, K A Foon, P G Abrams, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administrationJ A Knost, S A Sherwin, P G Abrams, et al.
Pageof 6